Figure 4.
The risk group stratification within each clinical stage in the primary cohort (a, all patients; b-c, stages) and in the validation cohort of the SCLC patents (d, all patients; e-f, stages) NSCLC, non-small-cell lung cancer; SCLC, small-cell lung cancer.